Open AccessOptimizing Regorafenib Dosing and Patient Management in Colorectal Cancer in Latin America: Perspectives from Argentina
Author(s) -
Dioca Mariano,
O'Connor Juan Manuel
Publication year - 2021
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1002/onco.13723
Subject(s) - regorafenib , latin americans , colorectal cancer , dosing , medicine , cancer , clinical trial , oncology , political science , law
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in Central and South America and one of the top causes of cancer death; however, these rates vary considerably between countries. This commentary focuses on clinical experiences in Argentina, highlighting results of the phase II ReDOS trial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom